We develop efficient, ultra-precise, and organic biological fungicides and bactericides
ABOUT US
We develop efficient, ultra-precise and organic biological fungicides and bactericides
ABOUT US

Why are we developing the next-gen of biological pesticides

>$220 billion
Crop diseases cause >$220 billion in annual losses
Global warming
perpetuates crop disease outbreaks, some of which destroy >50% of staple crops
Toxic and ineffective
Antimicrobial pesticides are often ineffective and toxic for humans and the environment
> 90% of Americans
have dangerous pesticides in their bodies

We develop safe and effective in different environments bactericides and fungicides

We use targeted approaches, including bacteriophages - safe bacterial viruses
#1 Research Pipeline
Saving the US citrus industry
NOW
Huanglongbing, also known as citrus greening, is a devastating and incurable disease of citruses that is destroying the US citrus industry
>3.2
citrus price increase
>40%
decrease in orange production
in 10-15
years, the industry is likely to disappear
Our solution
We’re developing a safe, precise, and organic bacteriophage-based solution to cure citrus greening
CONTACT US
#2 Pipeline
Platform technology to control fungal diseases in different environments
NOW
Fungal pathogens devastate agriculture
>80%
of crop diseases are caused by fungal organisms
Toxicity
Existing fungicides are often ineffective and can be toxic for humans and the environment
Advantages:
Uniphage’s fungicides are made to work in different environments
Our products have a significantly higher chance of in-field success. Long-term, this leads to more cost-efficient development and production of new solutions.
CONTACT US
We're developing cutting-edge AI algorithms to enable our solutions to be more efficient
Our solution
Our technology will allow to faster develop bacteriophage-based solutions that will work in real-life settings even against rare bacterial pathogens
1 stage of technology development
Predict phage-host interactions
Advantages:
Quickly and precisely finding characterized phages that will work in-field, thus significantly reducing the chance of unsuccessful and expensive field trials
Using the same or very similar phages for a range of diseases, reducing regulatory hurdles
Little additional characterization is necessary
2 stage of technology development
Modify phage-host interactions
Advantages:
Precise change of desired phage characteristics to increase phage effectiveness and change hosts
Subscribe to updates
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Mentor

Mentor 1
role
Description / introduction
Linkedin
Sofia Sigal-Passeck
founder and CEO | Biz Dev and Science
Sofia is a Yale-NUS alumna and a PI on an NSF SBIR grant. She is excited to use microbiology to build a safer and more sustainable world!
Linkedin
Mentor 2
ROLE
Description / introduction
Linkedin
Mentor 3
Role
Description / introduction
Linkedin
Mentor 4
ROLE
Description / Introduction
Linkedin

Contact us

to learn more about us building the next-gen biopesticide company

+1 234 567 89 01

contact@uniphage.com

Follow us on social media:
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.